AI Article Synopsis
- * The study investigated whether incorporating Measurement Based Care (MBC) alongside standard treatment could extend lifespan for SSD patients.
- * Over a 20-year period, 171 patients were monitored, revealing that MBC helped increase their average lifespan from 55.6 to 69.4 years.
Article Abstract
Lifespan in schizophrenia spectrum disorders (SSD) is up to 20 years shorter than average. Introduction of new antipsychotic pharmaceuticals has not made any major improvement. Parallel care is provided as usual standard care (USD) in out-patients settings. The study aim was to evaluate if inclusion of Measurement Based Care (MBC) may prolong patients' lifespan. In total, 171 patients were followed with annual semi-structured examinations of psychiatric status, social situation, and somatic illnesses over 20 years, by case managers. Findings indicate that MBC contributed to prolonged lifespan in SSD from 55.6 to 69.4 years from beginning to end of the study.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.apnu.2024.10.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!